$Tonix Pharmaceuticals(TNXP)$

$Tonix Pharmaceuticals(TNXP)$ i might need a vaccine to hold it for long @TigerGPT $Tonix Pharmaceuticals(TNXP)$

Sorry, this post has been deleted

Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

TigerGPT
12-17
TigerGPT
Based on the information available, it seems that there is no specific analysis or valuation data for Tonix Pharmaceuticals (TNXP) at the moment. However, there are some recent news articles related to the company:
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights: This article discusses Tonix Pharmaceuticals submitting a New Drug Application (NDA) to the FDA for TNX-102 SL for fibromyalgia. The company was also granted Fast Track Designation by the FDA for TNX-102 SL.

NDA Filed for TNX-102 SL in Fibromyalgia: This article highlights the filing of the NDA for TNX-102 SL in fibromyalgia by Tonix Pharmaceuticals.

Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs: Tonix Pharmaceuticals announced the expansion of its leadership team to support the launch of TNX-102 SL for the management of fibromyalgia.

Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference: This article mentions Tonix Pharmaceuticals' participation in the NobleCon20 Investor Conference.

Please note that the news articles provided are for informational purposes only and should not be considered as investment advice or a recommendation to hold Tonix Pharmaceuticals (TNXP) for the long term.
Remember to conduct thorough research and analysis before making any investment decisions. If you require more up-to-date and comprehensive information, I recommend reviewing the stock quote page or consulting with a professional financial advisor.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":382326195671112,"tweetId":"382326195671112","gmtCreate":1734372676287,"gmtModify":1734416061803,"author":{"id":4156648821928502,"idStr":"4156648821928502","authorId":4156648821928502,"authorIdStr":"4156648821928502","name":"Kallu","avatar":"https://community-static.tradeup.com/news/516672ce34e53607e5822f25111599cf","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.02","exceedPercentage":"60.79%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[{"themeId":"7516f9ef7e8042739b8597466da26fe7","categoryId":"7cf744760f454845a1870a05ea4e151d","name":"Winning Trades","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":7516f9ef7e8042739b8597466da26fe7}&rnconfig={\"headerBarHidden\": true}","description":"Share your positions with us! This is a column where you can find the winning trades of our fellow tigers. There probably are a few potential opportunities that you may have overlooked.","image":"https://community-static.tradeup.com/news/14c89d9656aedb9a4698e7996c575947"}],"images":[{"img":"https://community-static.tradeup.com/news/13e17785e1142024c8f2d6cec7b63255"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/13e17785e1142024c8f2d6cec7b63255"}],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$</a> i might &nbsp;need a vaccine to hold it for long <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<t-t type=\"img\" src=\"https://community-static.tradeup.com/news/13e17785e1142024c8f2d6cec7b63255\"></t-t></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$</a> i might &nbsp;need a vaccine to hold it for long <a href=\"https://ttm.financial/U/4141429963588842\">@TigerGPT</a><a href=\"https://ttm.financial/S/TNXP\">$Tonix Pharmaceuticals(TNXP)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;<t-t type=\"img\" src=\"https://community-static.tradeup.com/news/13e17785e1142024c8f2d6cec7b63255\"></t-t></body></html>","text":"$Tonix Pharmaceuticals(TNXP)$ i might need a vaccine to hold it for long @TigerGPT$Tonix Pharmaceuticals(TNXP)$","highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/382326195671112","repostId":2492611699,"repostType":2,"isVote":1,"tweetType":1,"viewCount":379,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["TNXP"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":true,"length":98,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":382539918090304,"commentId":"382539918090304","gmtCreate":1734372807729,"gmtModify":1734372812749,"authorId":4141429963588842,"author":{"id":4141429963588842,"idStr":"4141429963588842","authorId":4141429963588842,"name":"TigerGPT","avatar":"https://community-static.tradeup.com/news/5b82af1deb17dfa8f94b4741b9ea2738","vip":8,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":382326195671112,"objectIdStr":"382326195671112","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Based on the information available, it seems that there is no specific analysis or valuation data for Tonix Pharmaceuticals (TNXP) at the moment. However, there are some recent news articles related to the company:<a href=\"https://ttm.financial/NW/2492611699\">Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights</a>: This article discusses Tonix Pharmaceuticals submitting a New Drug Application (NDA) to the FDA for TNX-102 SL for fibromyalgia. The company was also granted Fast Track Designation by the FDA for TNX-102 SL.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2488923635\">NDA Filed for TNX-102 SL in Fibromyalgia</a>: This article highlights the filing of the NDA for TNX-102 SL in fibromyalgia by Tonix Pharmaceuticals.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2488919382\">Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs</a>: Tonix Pharmaceuticals announced the expansion of its leadership team to support the launch of TNX-102 SL for the management of fibromyalgia.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2486071647\">Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference</a>: This article mentions Tonix Pharmaceuticals' participation in the NobleCon20 Investor Conference.&nbsp;&nbsp;Please note that the news articles provided are for informational purposes only and should not be considered as investment advice or a recommendation to hold Tonix Pharmaceuticals (TNXP) for the long term.Remember to conduct thorough research and analysis before making any investment decisions. If you require more up-to-date and comprehensive information, I recommend reviewing the stock quote page or consulting with a professional financial advisor.","text":"Based on the information available, it seems that there is no specific analysis or valuation data for Tonix Pharmaceuticals (TNXP) at the moment. However, there are some recent news articles related to the company:<a href=\"https://ttm.financial/NW/2492611699\">Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights</a>: This article discusses Tonix Pharmaceuticals submitting a New Drug Application (NDA) to the FDA for TNX-102 SL for fibromyalgia. The company was also granted Fast Track Designation by the FDA for TNX-102 SL.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2488923635\">NDA Filed for TNX-102 SL in Fibromyalgia</a>: This article highlights the filing of the NDA for TNX-102 SL in fibromyalgia by Tonix Pharmaceuticals.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2488919382\">Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs</a>: Tonix Pharmaceuticals announced the expansion of its leadership team to support the launch of TNX-102 SL for the management of fibromyalgia.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2486071647\">Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference</a>: This article mentions Tonix Pharmaceuticals' participation in the NobleCon20 Investor Conference.&nbsp;&nbsp;Please note that the news articles provided are for informational purposes only and should not be considered as investment advice or a recommendation to hold Tonix Pharmaceuticals (TNXP) for the long term.Remember to conduct thorough research and analysis before making any investment decisions. If you require more up-to-date and comprehensive information, I recommend reviewing the stock quote page or consulting with a professional financial advisor.","html":"Based on the information available, it seems that there is no specific analysis or valuation data for Tonix Pharmaceuticals (TNXP) at the moment. However, there are some recent news articles related to the company:<a href=\"https://ttm.financial/NW/2492611699\">Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights</a>: This article discusses Tonix Pharmaceuticals submitting a New Drug Application (NDA) to the FDA for TNX-102 SL for fibromyalgia. The company was also granted Fast Track Designation by the FDA for TNX-102 SL.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2488923635\">NDA Filed for TNX-102 SL in Fibromyalgia</a>: This article highlights the filing of the NDA for TNX-102 SL in fibromyalgia by Tonix Pharmaceuticals.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2488919382\">Tonix Pharmaceuticals appoints Raudabaugh, Gould as VPs</a>: Tonix Pharmaceuticals announced the expansion of its leadership team to support the launch of TNX-102 SL for the management of fibromyalgia.&nbsp;&nbsp;<a href=\"https://ttm.financial/NW/2486071647\">Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference</a>: This article mentions Tonix Pharmaceuticals' participation in the NobleCon20 Investor Conference.&nbsp;&nbsp;Please note that the news articles provided are for informational purposes only and should not be considered as investment advice or a recommendation to hold Tonix Pharmaceuticals (TNXP) for the long term.Remember to conduct thorough research and analysis before making any investment decisions. If you require more up-to-date and comprehensive information, I recommend reviewing the stock quote page or consulting with a professional financial advisor.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/382326195671112"}